Literature DB >> 9647355

In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2.

V P Shah1, Y Tsong, P Sathe, J P Liu.   

Abstract

PURPOSE: To describe the properties of the similarity factor (f2) as a measure for assessing the similarity of two dissolution profiles. Discuss the statistical properties of the estimate based on sample means.
METHODS: The f2 metrics and the decision rule is evaluated using examples of dissolution profiles. The confidence interval is calculated using bootstrapping method. The bias of the estimate using sample mean dissolution is evaluated.
RESULTS: 1. f2 values were found to be sensitive to number of sample points, after the dissolution plateau has been reached. 2. The statistical evaluation of f2 could be made using 90% confidence interval approach. 3. The statistical distribution of f2 metrics could be simulated using 'Bootstrap' method. A relatively robust distribution could be obtained after more than 500 'Bootstraps'. 4. A statistical 'bias correction' was found to reduce the bias.
CONCLUSIONS: The similarity factor f2 is a simple measure for the comparison of two dissolution profiles. But the commonly used similarity factor estimate f2 is a biased and conservative estimate of f2. The bootstrap approach is a useful tool to simulate the confidence interval.

Mesh:

Year:  1998        PMID: 9647355     DOI: 10.1023/a:1011976615750

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  In-vitro dissolution profile comparison: statistics and analysis, model dependent approach.

Authors:  P M Sathe; Y Tsong; V P Shah
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

2.  Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations.

Authors:  H Malinowski; P Marroum; V R Uppoor; W Gillespie; H Y Ahn; P Lockwood; J Henderson; R Baweja; M Hossain; N Fleischer; L Tillman; A Hussain; V Shah; A Dorantes; R Zhu; H Sun; K Kumi; S Machado; V Tammara; T E Ong-Chen; H Mahayni; L Lesko; R Williams
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

3.  Statistical comparison between dissolution profiles of drug products.

Authors:  S C Chow; F Y Ki
Journal:  J Biopharm Stat       Date:  1997-05       Impact factor: 1.051

4.  Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.

Authors:  J E Polli; G S Rekhi; L L Augsburger; V P Shah
Journal:  J Pharm Sci       Date:  1997-06       Impact factor: 3.534

5.  Analysis of in vitro dissolution of whole vs. half controlled-release theophylline tablets.

Authors:  V P Shah; L A Yamamoto; D Schuirman; J Elkins; J P Skelly
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

  5 in total
  94 in total

1.  Biometrical evaluation of bioequivalence trials using a bootstrap individual direct curve comparison method.

Authors:  E Zintzaras; P Bouka; A Kowald
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

2.  Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology.

Authors:  Jiahui Hu; True L Rogers; Judith Brown; Tim Young; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

3.  Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.

Authors:  Neeraj Kumar; Gulshan Bansal; Sandeep Kumar; Asim Kumar Jana
Journal:  AAPS PharmSciTech       Date:  2012-06-06       Impact factor: 3.246

4.  DDSolver: an add-in program for modeling and comparison of drug dissolution profiles.

Authors:  Yong Zhang; Meirong Huo; Jianping Zhou; Aifeng Zou; Weize Li; Chengli Yao; Shaofei Xie
Journal:  AAPS J       Date:  2010-04-06       Impact factor: 4.009

5.  New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

6.  Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?

Authors:  Dorys Argelia Diaz; Stephen T Colgan; Connie S Langer; Nagesh T Bandi; Michael D Likar; Leslie Van Alstine
Journal:  AAPS J       Date:  2015-10-01       Impact factor: 4.009

7.  Terminalia gum as a directly compressible excipient for controlled drug delivery.

Authors:  Oluyemisi A Bamiro; Oluwatoyin A Odeku; Vivek R Sinha; Ruchita Kumar
Journal:  AAPS PharmSciTech       Date:  2011-11-09       Impact factor: 3.246

8.  Acoustic-resonance spectrometry as a process analytical technology for rapid and accurate tablet identification.

Authors:  Joseph Medendorp; Robert A Lodder
Journal:  AAPS PharmSciTech       Date:  2006-03-17       Impact factor: 3.246

9.  Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests.

Authors:  Pseidy L Mamani; Roberto Ruiz-Caro; María D Veiga
Journal:  AAPS PharmSciTech       Date:  2012-08-21       Impact factor: 3.246

10.  Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum.

Authors:  Mukesh C Gohel; Rajesh K Parikh; Stavan A Nagori; Dillip G Jena
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.